ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 529–540 of 2020 project topics
Liquid Biopsy Somatic Mosaicism Profiling Platform
Commercial laboratory platform extracting and analyzing mosaic somatic mutations from blood and body fluids for early disease detection and monitoring. Captures growing oncology and personalized medicine markets by enabling minimal-invasive, longitudinal tracking of clonal evolution and treatment response.
Genetic Mosaicism Detection Methods Click to view more details →
Whole Genome Sequencing Mosaic Data Management Dashboard
Enterprise-grade software dashboard integrating WGS data processing, mosaic variant visualization, and clinical reporting in a single consolidated platform. Streamlines diagnostic workflows for medical centers and genomics labs, reducing infrastructure costs while enabling subscription-based recurring revenue models.
Genetic Mosaicism Detection Methods Click to view more details →
FBN1 and FBN2 Marfan Syndrome Variant Analysis
Characterizing pathogenic variants in fibrillin genes for diagnosing Marfan syndrome and differentiating from related fibrillinopathies.
Genetic Basis of Connective Tissue Disorders Click to view more details →
Ehlers-Danlos Syndrome Gene Panel Testing
Developing comprehensive EDS gene panels covering COL5A1, COL5A2, COL3A1, and TNXB for molecular diagnosis of different EDS subtypes.
Genetic Basis of Connective Tissue Disorders Click to view more details →
Loeys-Dietz Syndrome TGFBR Variant Characterization
Identifying and classifying TGFBR1, TGFBR2, SMAD3, and TGFB2 variants causing Loeys-Dietz syndrome and correlating with aortic risk.
Genetic Basis of Connective Tissue Disorders Click to view more details →
Hereditary Thoracic Aortic Disease Gene Testing
Developing gene panels for HTAD including ACTA2, MYH11, and MYLK genes for identifying families at risk for thoracic aortic aneurysm and dissection.
Genetic Basis of Connective Tissue Disorders Click to view more details →
COL1A1/COL1A2 Osteogenesis Imperfecta Diagnostic SaaS Platform
A cloud-based diagnostic platform that sequences and interprets COL1A1 and COL1A2 variants to classify osteogenesis imperfecta severity and predict fracture risk in pediatric and adult patients. Enables labs to offer rapid molecular diagnosis with automated severity grading, improving clinical outcomes and establishing recurring subscription revenue through subscription-based testing services.
Genetic Basis of Connective Tissue Disorders Click to view more details →
ADAMTS2 Dermatosparaxis Type VIII EDS Analysis Toolkit
A commercial bioinformatics toolkit that identifies pathogenic ADAMTS2 variants associated with dermatosparaxis-type Ehlers-Danlos syndrome through variant effect prediction and protein modeling. Generates clinical reports with treatment recommendations that diagnostic labs can resell to dermatologists and geneticists, creating differentiated service offerings and premium pricing tiers.
Genetic Basis of Connective Tissue Disorders Click to view more details →
PLOD1/PLOD2/PLOD3 Kyphoscoliotic EDS Predictive Biomarker Engine
An AI-powered biomarker analysis engine that detects PLOD gene variants and correlates genotype with kyphoscoliotic EDS progression rates and spinal deformity severity. Provides prognostic insights and treatment monitoring data that orthopedic and neurology clinics can integrate into their patient management workflows, generating data licensing and platform licensing revenue.
Genetic Basis of Connective Tissue Disorders Click to view more details →
SERPINH1 Collagen-Related Osteochondrodysplasia Variant Classification Tool
A specialized molecular analysis tool that characterizes SERPINH1 mutations causing Osteochondrodysplasia with Mild Skeletal Changes and Connective Tissue Involvement through automated variant interpretation. Targets rare disease diagnostic labs with white-label licensing options and per-test fees, capturing market share in skeletal dysplasia testing.
Genetic Basis of Connective Tissue Disorders Click to view more details →
FKBP14 Ehlers-Danlos Kyphoscoliotic Type Clinical Decision Support System
A clinical decision support platform that integrates FKBP14 variant data with phenotypic patient information to predict muscular complications and recommend preventive interventions. Serves rheumatology and physiatry practices with real-time treatment recommendations, generating subscription revenue and improving patient adherence through integrated patient portals.
Genetic Basis of Connective Tissue Disorders Click to view more details →
CHST14/DSE Musculocontractural EDS Carrier Screening and Risk Stratification SaaS
A comprehensive carrier screening platform that detects CHST14 and DSE pathogenic variants in at-risk populations for musculocontractural EDS, with automated risk stratification and genetic counseling recommendations. Enables prenatal testing centers and fertility clinics to offer expanded panel testing with interpretive reports, creating recurring testing volume and premium counseling service fees.
Genetic Basis of Connective Tissue Disorders Click to view more details →